Nonetheless, PTEN knock-down increased the expression of p-AKT as well as the likelihood of cell death induced by dual PI3K/mTOR inhibitors in SCLC cell lines with low p-AKT levels (i.e., NCI-H146 and NCI-H526) (Fig. 4D). The gene discussed is PIK3CB; the disease is small cell lung carcinoma.